Table 1 Risk factors for death in TB patients

Gender

Female (Ref)

13 834 (44.64)

1

1

1

-

-

Male

17 157 (55.30)

1.0 (0.9–1.2)

0.8 (0.6–1.0)

0.8 (0.7–0.9)

-

-

Age (years)

≤7 (Ref)

943 (3.04)

1

1

1

1

1

8–17

472 (1.52)

1.4 (1.2–1.6)

1.9 (1.6–2.3)

2.0 (1.5–2.7)

2.0 (1.3–3.2)

2.0 (1.8–2.2)

18–49

23 266 (75.07)

4.1 (3.8–4.5)

4.0 (3.0–5.4)

5.8 (4.0–8.4)

6.4 (4.5–9.0)

5.3 (3.6–7.9)

50–64

5 094 (16.44)

5.2 (4.1–6.6)

4.4 (2.9–6.5)

7.7 (4.6–12.7)

9.0 (6.0–13.4)

6.8 (3.9–12.1)

≥65

1 216 (3.92)

8.4 (7.2–9.9)

7.5 (6.1–9.2)

14.4 (10.3–20.2)

13.8 (10.1–18.9)

14.4 (9.9–21.0)

HIV status

Negative (Ref)

1 787 (5.77)

1

1

1

1

1

Positive

10 748 (34.68)

2.2 (2.0–2.5)

1.6 (1.4–1.9)

1.8 (1.6–2.1)

2.4 (2.1–2.8)

1.9 (1.7–2.1)

Unknown

18 456 (59.55)

2.8 (2.6–3.0)

1.9 (1.7–2.1)

2.4 (2.2–2.5)

2.8 (2.5–3.1)

2.4 (2.2–2.6)

Pre-treatment sputum smear result

Smear + (Ref)

12 047 (38.87)

1

1

1

1

1

Smear -

7 375 (23.80)

1.5 (1.4–1.7)

1.3 (1.2–1.5)

1.4 (1.3–1.6)

1.4 (1.2–1.6)

1.5 (1.3–1.6)

No result

11 569 (37.33)

1.6 (1.4–1.8)

1.9 (1.4–2.6)

2.1 (1.4–3.2)

2.3 (1.5–3.4)

2.0 (1.3–3.1)

Treatment category

New (Ref)

24 587 (79.34)

1

1

1

1

1

Retreatment

6 404 (20.66)

1.4 (1.3–1.5)

1.4 (1.3–1.5)

1.3 (1.2–1.4)

1.3 (1.2–1.4)

1.3 (1.2–1.4)

Disease classification

Both (Ref)

776 (2.50)

1

1

1

1

1

PTB

23 210 (74.89)

1.3 (1.0–1.5)

1.0 (1.0–1.1)

1.0 (0.9–1.1)

1.0 (0.8–1.2)

1.0 (0.7–1.4)

EPTB

7 005 (22.60)

0.8 (0.6–0.9)

1.1 (0.9–1.3)

1.0 (0.8–1.2)

1.0 (0.8–1.1)

1.0 (0.7–1.3)

Treatment delay

≤14 days (Ref)

12 820 (41.37)

1

1

1

1

1

>14 days

3 244 (10.47)

1.0 (0.9–1.1)

0.9 (0.9–1.0)

0.9 (0.9–1.0)

0.9 (0.8–1.0)

0.9 (0.9–1.0)

Missing

14 927 (48.17)

1.4 (1.3–1.5)

1.1 (0.9–1.2)

1.0 (0.9–1.2)

1.0 (0.9–1.1)

1.1 (0.9–1.3)

HIV status x gender^a

Male x HIV positive

-

-

1.23 (1.15–1.32)

1.33 (1.26–1.41)

-

-

Male x HIV unknown

-

-

1.16 (1.09–1.25)

1.20 (1.15–1.25)

-

-